← Назад к работе
Работы, на которые ссылается эта работа
Работ: 70
Работа: Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
Zobair M. Younossi, Aaron B. Koenig, Dinan Abdelatif +3
Обзорная статья2015Цитирований: 7ABI2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
Michael D. Jensen, Donna H. Ryan, Caroline M. Apovian +16
Статья2013Цитирований: 3ABINon-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
Giovanni Targher, Christopher D. Byrne, Amedeo Lonardo +2
Обзорная статья2016Цитирований: 3ABIMechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease
Обзорная статья2004Цитирований: 2ABIEuropean Association for the Study of the Liver (<scp>EASL</scp>), European Association for the Study of Diabetes (<scp>EASD</scp>) and European Association for the Study of Obesity (<scp>EASO</scp>) clinical practice recommendations for the management of non‐alcoholic fatty liver disease: evaluation of their application in people with Type 2 diabetes
Anne-Laure Sberna, Benjamin Bouillet, Alexia Rouland +9
Статья2017Цитирований: 2ABINonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and Management
Thomas Marjot, Ahmad Moolla, Jeremy Cobbold +2
Обзорная статья2019Цитирований: 2ABI